A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

Emma L Pennery

doi:10.1186/bcr1803

Abstract

A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

Highlights

Investment in terms of cancer budgets will inevitably always be somewhat biased toward the most significant health problems, and probably justifiably so
At any one time in the UK there are an estimated 172,000 people living with breast cancer, as compared with 77,000 with colorectal cancer, 32,000 with lung cancer and 31,000 with melanoma
The significance and prevalence of breast cancer as a major health problem within the UK is reflected in government targets and plans, which commonly cite breast cancer as a priority area [2]

Summary

Introduction

Investment in terms of cancer budgets will inevitably always be somewhat biased toward the most significant health problems, and probably justifiably so. Breast cancer has the highest incidence of any cancer in the UK, with more than 44,000 new cases diagnosed each year [1]. The significance and prevalence of breast cancer as a major health problem within the UK is reflected in government targets and plans, which commonly cite breast cancer as a priority area [2].

Results

Conclusion